• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer.

作者信息

Eze Chukwuka, Belka Claus, Manapov Farkhad

机构信息

Department of Radiation Oncology, University Hospital LMU Munich, Munich, Germany.

German Cancer Consortium, partner site Munich, Munich, Germany.

出版信息

JAMA Oncol. 2021 Sep 1;7(9):1341-1342. doi: 10.1001/jamaoncol.2021.2316.

DOI:10.1001/jamaoncol.2021.2316
PMID:34323949
Abstract
摘要

相似文献

1
Forging a Path for Metformin Use in Inoperable Locally Advanced Non-Small Cell Lung Cancer.为二甲双胍在不可切除的局部晚期非小细胞肺癌中的应用开辟道路。
JAMA Oncol. 2021 Sep 1;7(9):1341-1342. doi: 10.1001/jamaoncol.2021.2316.
2
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer.一项关于二甲双胍联合吉非替尼作为局部晚期非小细胞肺癌一线治疗的多中心双盲II期研究。
Clin Lung Cancer. 2017 May;18(3):340-343. doi: 10.1016/j.cllc.2016.12.003. Epub 2016 Dec 22.
3
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.一项针对局部晚期非小细胞肺癌老年患者的诱导化疗后序贯同步放化疗的II期研究。
Anticancer Drugs. 2007 Jul;18(6):713-9. doi: 10.1097/CAD.0b013e328082558a.
4
[A randomized study on the effects of paclitaxel liposme and cisplatin induction chemotherapy followed concurrent chemoradiotherapy and sequential radiotherapy on locally advanced non-small cell lung cancer patients].[一项关于紫杉醇脂质体和顺铂诱导化疗后序贯同步放化疗及序贯放疗对局部晚期非小细胞肺癌患者疗效的随机研究]
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):137-40. doi: 10.3779/j.issn.1009-3419.2011.02.06.
5
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer.不可切除的 III 期非小细胞肺癌的同步放化疗
Curr Oncol Rep. 2003 Jul;5(4):313-7. doi: 10.1007/s11912-003-0073-z.
6
Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer.塞来昔布联合多西他赛同步放化疗，序贯多西他赛加顺铂巩固化疗并联合塞来昔布维持治疗不可切除的Ⅲ期非小细胞肺癌的Ⅱ期研究
Asia Pac J Clin Oncol. 2018 Feb;14(1):91-100. doi: 10.1111/ajco.12749. Epub 2017 Aug 25.
7
Chemoradiotherapy for lung cancer: current status and perspectives.肺癌的放化疗：现状与展望
Int J Clin Oncol. 2004 Dec;9(6):435-43. doi: 10.1007/s10147-004-0453-x.
8
The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.诱导化疗对后续放疗剂量学参数的影响：对30例连续的局部晚期非小细胞肺癌患者及现代放射治疗计划技术的研究。
Radiat Oncol. 2015 Jan 31;10:32. doi: 10.1186/s13014-015-0332-9.
9
Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.局部晚期非小细胞肺癌患者接受化疗和胸部放疗的意愿。
Psychooncology. 2009 May;18(5):483-9. doi: 10.1002/pon.1450.
10
The Role of Additional Chemotherapy in Combination with Concurrent Chemoradiotherapy for Locally Advanced Inoperable Non-Small Cell Lung Cancer, a Systematic Review and Meta-Analysis of 12 Randomized Trials.局部晚期不可手术非小细胞肺癌同步放化疗中加入辅助化疗的作用：12 项随机试验的系统评价和荟萃分析。
Cancer Invest. 2019;37(8):376-386. doi: 10.1080/07357907.2019.1656730. Epub 2019 Sep 2.

引用本文的文献

1
Analysis of factors influencing lung cancer in patients with type 2 diabetes mellitus.2型糖尿病患者肺癌影响因素分析
Medicine (Baltimore). 2025 Jul 4;104(27):e43054. doi: 10.1097/MD.0000000000043054.
2
Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?局部晚期非小细胞肺癌的代谢靶向治疗、免疫治疗和放射治疗：我们从这里走向何方？
Front Oncol. 2022 Dec 14;12:1016217. doi: 10.3389/fonc.2022.1016217. eCollection 2022.
3
Addition of metformin to non-small-cell lung cancer patients with or without diabetes.
在患有或未患有糖尿病的非小细胞肺癌患者中添加二甲双胍。
Thorac Cancer. 2023 Jan;14(2):218-219. doi: 10.1111/1759-7714.14756. Epub 2022 Nov 30.
4
Metformin: A promising drug for human cancers.二甲双胍：一种对人类癌症有前景的药物。
Oncol Lett. 2022 May 12;24(1):204. doi: 10.3892/ol.2022.13325. eCollection 2022 Jul.
5
Metformin Intervention-A Panacea for Cancer Treatment?二甲双胍干预——癌症治疗的万灵药？
Cancers (Basel). 2022 Mar 4;14(5):1336. doi: 10.3390/cancers14051336.
6
Metabolic response to radiation therapy in cancer.癌症放射治疗的代谢反应。
Mol Carcinog. 2022 Feb;61(2):200-224. doi: 10.1002/mc.23379. Epub 2021 Dec 27.